Scientists search for clues in liver cancer Patients' blood and tissue

NCT ID NCT05197504

Summary

This study aimed to discover biological markers that could predict how patients with advanced liver cancer respond to a specific drug combination. Researchers analyzed blood and tumor tissue samples from 166 patients who had already received the treatment. The goal was to find patterns in the samples that could help doctors better understand and classify the disease in the future.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHA Bundang Medical Center

    Seongnam-si, Gyeonggi-do, 13496, South Korea

Conditions

Explore the condition pages connected to this study.